Winward D B, Brophy M T
Section of Clinical Pharmacy, Veterans Administration Medical Center, Boston, Massachusetts, USA.
Pharmacotherapy. 1995 Nov-Dec;15(6):765-72.
Within in last 7 years the literature has published several reports of acute renal failure after the administration of intravenous immunoglobulin. Review of these cases finds that all occurrences in the United States except one involved a sucrose-containing immunoglobulin preparation, leading to the suspicion that sucrose may be the cause of the renal failure. Further investigation found that approximately 50 years ago, when sucrose was used as an osmotic diuretic, investigators reported acute renal failure in humans after intravenous infusions of 50 g or more. A patient at our institution developed acute renal failure similar to that described in published case reports after being administered a sucrose-containing immunoglobulin.
在过去7年里,文献中发表了几篇关于静脉注射免疫球蛋白后出现急性肾衰竭的报告。对这些病例的回顾发现,在美国除了1例之外,所有病例都涉及含蔗糖的免疫球蛋白制剂,这引发了人们对蔗糖可能是肾衰竭病因的怀疑。进一步调查发现,大约50年前,当蔗糖被用作渗透性利尿剂时,研究人员报告称,静脉输注50克或更多蔗糖后,人类会出现急性肾衰竭。我们机构的一名患者在使用含蔗糖的免疫球蛋白后出现了与已发表病例报告中描述的类似的急性肾衰竭。